0000899243-19-002190.txt : 20190130 0000899243-19-002190.hdr.sgml : 20190130 20190130160701 ACCESSION NUMBER: 0000899243-19-002190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190128 FILED AS OF DATE: 20190130 DATE AS OF CHANGE: 20190130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mobasher Mehrdad CENTRAL INDEX KEY: 0001765484 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 19552005 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-28 0 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001765484 Mobasher Mehrdad CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 3.88 2019-01-28 4 A 0 210000 0.00 A 2029-01-28 Common Stock 210000 210000 D The underlying shares subject to the option vest and become exercisable as to twenty-five percent (25%) of the shares subject to the option on January 28, 2020, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Leiv Lea, as Attorney-in-Fact for Mehrdad Mobasher 2019-01-30